Tom Hochuli joined Vibalogics as CEO in July 2020 and leads our U.S. operations and global commercial activity. Tom has more than 25 years of experience in the biopharma industry and has a proven track record not only establishing but growing successful and thriving commercial scale cell and gene therapy manufacturing facilities.
Before joining us at Vibalogics, Tom was Head of Cell and Gene Therapy Operations and Site Head of Lonza’s Houston facility, the world’s largest dedicated cell and gene therapy manufacturing facility covering 300,000 sq. ft. Under his leadership, the site went from greenfield to GMP ready in just six months, doubled revenue every year for two consecutive years and increased headcount from 150 to 500 employees over the same period. While at Lonza, Tom was directly responsible for overseeing more than 40 cell and gene therapy client relationships, including early phase, late phase, and commercial manufacturing.